9 months fin/dut + topical min + estrogen. Doing a happy dance!
    7/14/2025

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Dutasteride →

    Heavy duty finasteride that comes with higher risks

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this success story post, the primary subjects mentioned are
    💊 Finasteride (oral) 1mg 3 months
    💊 Dutasteride (oral) 0.5mg 6 months
    💧 Minoxidil (topical) 9 months
    💊 Estrogen (oral) 9 months
    the tone is 😀 positive with significant regrowth results.

    Other terms

    The post discusses a user's successful hair regrowth using finasteride, dutasteride, topical minoxidil, and estrogen over nine months. The user, who is male-to-female (mtf), reports significant regrowth and no side effects beyond typical hormone replacement therapy effects.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

      community Transplant Candidate? (26, Male)

       40 upvotes 8 months ago
      A 26-year-old male considering a hair transplant is using topical finasteride and minoxidil, planning to start feminizing hormone replacement therapy (HRT) with estrogen and spironolactone. Many suggest waiting to see the effects of HRT, which may significantly regrow hair, before deciding on a transplant, and recommend adding microneedling and possibly switching to oral treatments for better results.

      community DIY Testosterone replacement therapy and fin

       15 upvotes 4 months ago
      An 18-year-old is considering testosterone replacement therapy with finasteride or dutasteride for hair loss but worries about side effects. Users recommend alternatives like minoxidil, RU58841, and consulting a doctor.

      community 2 years on treatment (stack update)

       465 upvotes 1 year ago
      A user shared their hair regrowth progress using Dutasteride, topical Minoxidil, Spironolactone, and Estradiol Valerate injections as part of hormone replacement therapy for transitioning. They experienced significant hair improvement and personal satisfaction but caution against this approach for non-transitioning individuals due to irreversible changes.

      community My 2 Years Progress (Hair Recovery)

       1465 upvotes 5 months ago
      A person shared their hair regrowth journey using HIMS topical treatments with finasteride, minoxidil, hormone replacement therapy (HRT), and microneedling. They also discussed their transition as a transgender woman and the positive impact of HRT on hair recovery.

      community Regrowth after 9 months of DHT blockers, and 6 months of HRT

      in Transgender  24 upvotes 10 months ago
      A 20-year-old saw significant hair regrowth after 9 months of using DHT blockers (finasteride and dutasteride) and 6 months of hormone replacement therapy (HRT) with estradiol. The regrowth is attributed to low testosterone and high estradiol levels, without using Minoxidil.

    Related Research

    6 / 6 results
      Hair Biology

      research Hair Biology

      33 citations , August 2018 in “Facial Plastic Surgery Clinics of North America”
      This review discusses various biologics for hair aging but reports no agent capable of reversing the natural aging process of hair.
      Female Pattern Alopecia: Current Perspectives

      research Female pattern alopecia: current perspectives

      42 citations , August 2013 in “International Journal of Women's Health”
      This review discusses the current therapeutic options for female pattern hair loss and emphasizes the need for managing patient expectations of permanent regrowth, reporting no new clinical results.
      Androgenetic Alopecia: A Review and Emerging Treatments

      research Androgenetic Alopecia: a Review and Emerging Treatments

      1 citations , July 2017 in “Clinical research in dermatology”
      This review covers the pathogenesis, diagnosis, and potential new treatments for androgenetic alopecia but reports no new clinical findings, highlighting an ongoing need for effective therapies.